On Monday, July 20, Oxford University announced good news--the team said their candidate coronavirus vaccine showed promising results. The vaccine is set to be widely-produced and distributed by September. Here's the problem, though. New speculation is ruining the name of Oxford University, and it involves their newly-created drug.
Oxford does 'challenge trials'?
Tech Times reported on Monday that the University of Oxford had announced the good news to all. British researchers created an experimental vaccine that was found with unwavering 'early results' that can trigger the immune response of a COVID-19 patient.
"We are seeing good immune response in almost everybody," said Dr. Adrian Hill, the Jenner Institute director at Oxford. "What this vaccine does particularly well is triggered both arms of the immune system."
According to the report, the experimental vaccine known as AZD1222 tested over 1,000 people in April. The results came very promisingly, which said to developed T-cells and antibodies in the human body that can fight the SARS-CoV-2 virus.
